Human cytomegalovirus latency, reactivation and immune control
Human cytomegalovirus latency, reactivation and immune control
批准号:
G0701279/1
负责人:
John Sinclair
金额:
$213.93万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Human cytomegalovirus (HCMV) is a virus which is carried without symptoms by the majority of the population. However, it can cause serious disease in infants born to mothers who acquire the infection in pregnancy and in people whose immune system is suppressed. Understanding how the virus succeeds in maintaining itself in most people without causing disease and how this relationship breaks down to cause disease should help develop better methods of treating the virus and of designing a vaccine (there is currently no vaccine available). Our research is aimed at determining (i) the mechanism by which the virus maintains silent infection (latency) in specialised cells of the immune system and the factors that reawake it and (ii) how the immune system controls the infection in normal people. In addition to advancing our understanding of HCMV in particular, this research may also lead to a better understanding of other virus infections which persist in the body, and how the human host controls them.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding human cytomegalovirus latency as a means to target the latent reservoir
-
批准号:MR/S00081X/1
-
项目类别:Research Grant
-
资助金额:$237.56万
-
财政年份:2018
-
负责人:John Sinclair
-
依托单位:
Human cytomegalovirus: changes in the latently infected cell as chemotherapeutic and immunological targets for antiviral therapy
-
批准号:MR/K021087/1
-
项目类别:Research Grant
-
资助金额:$203.5万
-
财政年份:2013
-
负责人:John Sinclair
-
依托单位:
海外基金